EWMA Conference 2017

ADVANCED THERAPIES

BACKGROUND

According to various forecasts and estimates, the size of the global biomaterial market is expected to reach €100 billion by the year 2020 from a mere €20 billion over the preceding 15 years, with a compound annual growth rate of between 10 and 15%. Increased investment, of a public and private nature, technological advances, greater scope of use and not least an ageing population will promote the growth of the global biomaterial market.

AIM AND OBJECTIVES OF THE PROJECT

This document will investigate and provide an outlook on the barriers and possibilities of advanced therapies in next generation wound management. Cellular therapies, tissue engineering and tissue substitutes are all techniques associated with the clinical discipline of regenerative medicine and will be covered here. Moreover, a focus on physical therapies and the potential of sensors and software will be included.

The document will include literature review and expert opinion on where the opportunities lie ahead and call for research in recommended areas.

The document will seek to:

• Provide overview and outlook on the opportunities in this multi-faceted  and complex field
• Review and discuss clinical experiences and the evidence beyond them
• Provide recommendation for the adoption of advanced therapies in the different areas of wound management
• Analyze and debate cost-effectiveness issues
• Discuss the role of policymakers, payers and legislators regarding the regulatory framework for Advanced Therapies.

This key session will introduce the EWMA initiative and the current considerations concerning barriers and possibilities of advanced therapies in next generation wound management.